Serum CGRP in migraine patients using erenumab as preventive treatment

Aim Serum levels of Calcitonin Gene-Related Peptide (CGRP)-like immunoreactivity (CGRP-LI) in migraine patients before and after starting treatment with erenumab were measured to evaluate the association with clinical treatment response. Methods Blood samples were collected from the cubital fossa be...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of headache and pain Ročník 23; číslo 1; s. 120 - 7
Hlavní autori:	de Vries Lentsch, Simone, Garrelds, Ingrid M., Danser, A. H. Jan, Terwindt, Gisela M., MaassenVanDenBrink, Antoinette
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Milan Springer Milan 01.12.2022 Springer Nature B.V BMC
Predmet:	Calcitonin Calcitonin gene-related peptide CGRP Headache Immunoreactivity Internal Medicine Medicine Medicine & Public Health Migraine Monoclonal antibodies Neurology Pain Medicine Patients Peptides Radioimmunoassay Regression analysis Serum Serum levels Monoclonal antibodies Serum CGRP Migraine
ISSN:	1129-2369, 1129-2377, 1129-2377
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!